R1 RCM


R1 RCM is an American healthcare revenue cycle management company servicing hospitals, health systems and physician groups across the United States. The company provides end-to-end revenue cycle management services as well as modular services targeted across the revenue cycle including pre-registration, financial clearance, charge capture, coding, billing and follow-up, underpayments, and denials management.

History

R1 RCM was founded as Accretive Health in 2003 by Mary Tolan and Michael Cline. Tolan served as the company's president, chief executive officer, and board director until 2013. Cline served as board chairman between 2009 and 2013.
In July 2011, an Accretive Health employee's laptop containing unencrypted patient data was stolen from their personal vehicle.
In 2012, responding to a Senate inquiry, the company stated that nine thefts of patient data-bearing company laptops had occurred in 2011, and that 30 company laptops had lacked encryption. As a consequence, in 2013, Accretive Health entered into a 20-year settlement with the Federal Trade Commission over its data security measures.
In July 2012, Accretive Health entered into a $2.5 million settlement with the Minnesota Attorney General following an investigation into the company's debt collection practices. The company admitted no wrongdoing.
In April 2013, Mary Tolan stepped down as CEO. Tolan was replaced by former Dell executive Stephen Schuckenbrock.
In March 2014, as a result of missed financial restatements, Accretive Health was delisted from the New York Stock Exchange. Over-the-counter trading continued.
On July 21, 2014, Emad Rizk replaced Schuckenbrock as CEO.
In December 2014, the company restated certain previously filed financial statements and, in June 2015, announced that they had completed their 2014 SEC filings The company filed its 2015 Q2 10-Q with the SEC in August 2015.
In 2015, Ascension selected Accretive Health as its exclusive hospital revenue cycle partner. As part of the transaction, Ascension and TowerBrook Capital Partners invested $200M to support growth initiatives at Accretive Health.
In 2017, Accretive Health was renamed as R1 RCM.
In mid-2017, R1 RCM announced a further expansion of the agreement with Ascension to include an additional $1.5B in net patient revenue handled, which included physician group revenue cycle services.
In February 2018, R1 RCM announced it had agreed to acquire Intermedix Corporation for approximately $460 Million.

Layoffs

In 2017, R1 RCM laid off 20% of total employee strength most of which included software developers as a part of company's annual performance review process. These are the pros and cons of merger and acquisition. The Company's financial performance predicts whether a company would expand or cut off their employees.